Market Cap 273.29M
Revenue (ttm) 51.29M
Net Income (ttm) -59.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -116.92%
Debt to Equity Ratio 0.85
Volume 221,200
Avg Vol 194,026
Day's Range N/A - N/A
Shares Out 26.15M
Stochastic %K 98%
Beta 1.26
Analysts Strong Sell
Price Target $10.83

Company Profile

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was...

Industry: Medical Devices
Sector: Healthcare
Phone: 763 416 2840
Fax: 763 416 2841
Address:
9201 West Broadway Avenue, Suite 650, Minneapolis, United States
Twister8
Twister8 Oct. 23 at 4:37 PM
$CVRX when is the company going break out of the malaise and show some impressive growth? Donald?
1 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 23 at 2:12 PM
$CVRX CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
1 · Reply
MedDevice
MedDevice Oct. 21 at 11:40 PM
$CVRX I’m excited to see if these new site launches get revenue per center over 2 per quarter. If they don’t, it’s all PR.
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 21 at 6:37 PM
$CVRX We're proud to support Dr. Tara Hrobowski, Dr. Christiano Caldeira and the Heart Failure and CT Surgery teams at HCA Florida Largo Hospital on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1980382997833740637
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 19 at 2:01 PM
$CVRX We were honored to partner with Drs. Sevak Darbinian, Daniel Kulick, and Jay Tiogson and the team at Providence Mission Hospital on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1979197996337123804
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 17 at 4:58 PM
$CVRX INTERESTING that with hardly any news, hardly any following, CVRX in less than 6 months has more than doubled in price. On May 12th it closed at $4.75 and most messages called for doom and gloom. Of course the share price is still only about 1/3 of what it was at its peak 2 years ago.
3 · Reply
Twister8
Twister8 Oct. 17 at 2:39 PM
$CVRX trimmed
1 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 14 at 3:18 PM
$CVRX The #ASCENDHF kickoff meeting was a success, thanks to the contributions of the Course Directors, faculty, and Fellows. The collective dedication to advancing #heartfailure care, along with their commitment to ongoing learning, collaboration, and exceptional patient care, was inspiring. We're looking forward to the fellows building on this momentum and can’t wait for our next meeting! https://x.com/CVRx_Barostim/status/1977723701870104754
1 · Reply
MedDevice
MedDevice Oct. 12 at 9:02 PM
$CVRX https://x.com/cvrx_barostim/status/1967711764360876131?s=46
1 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 11 at 9:28 PM
$CVRX Post CVRx | Barostim @CVRx_Barostim Our 2nd ASCEND Fellows Summit is officially underway in Minneapolis! It's the kickoff of a multi-course program designed for Heart Failure and General Cardiology fellows to explore treatment options for Heart Failure earlier in the care continuum. We are proud to help foster scientific collaboration with this exceptional group of fellows and faculty. https://x.com/CVRx_Barostim/status/1976774914066522505
0 · Reply
Latest News on CVRX
CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 7:27 PM EDT - 2 months ago

CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript


CVRx Announces Positive News on Outpatient Payment for Barostim

Jul 16, 2025, 7:30 AM EDT - 3 months ago

CVRx Announces Positive News on Outpatient Payment for Barostim


CVRx: Sell-Off Ignores Its True Potential

Jul 2, 2025, 4:02 AM EDT - 4 months ago

CVRx: Sell-Off Ignores Its True Potential


CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript

May 10, 2025, 3:51 PM EDT - 6 months ago

CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript


CVRx Inc: Overreaction Creates Buying Opportunity

Apr 9, 2025, 8:45 AM EDT - 7 months ago

CVRx Inc: Overreaction Creates Buying Opportunity


CVRx Reports Preliminary First Quarter 2025 Financial Results

Apr 7, 2025, 4:05 PM EDT - 7 months ago

CVRx Reports Preliminary First Quarter 2025 Financial Results


CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript

Feb 4, 2025, 11:00 PM EST - 9 months ago

CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript


CVRx: Impressive Top-Line Growth Seems Priced In

Nov 6, 2024, 9:04 PM EST - 1 year ago

CVRx: Impressive Top-Line Growth Seems Priced In


CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 10:38 PM EDT - 1 year ago

CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript


CVRx announces new CPT® Category I codes for Barostim

Oct 18, 2024, 2:08 PM EDT - 1 year ago

CVRx announces new CPT® Category I codes for Barostim


CVRx Announces Appointment of Two New Board Members

Sep 3, 2024, 8:30 AM EDT - 1 year ago

CVRx Announces Appointment of Two New Board Members


Twister8
Twister8 Oct. 23 at 4:37 PM
$CVRX when is the company going break out of the malaise and show some impressive growth? Donald?
1 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 23 at 2:12 PM
$CVRX CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
1 · Reply
MedDevice
MedDevice Oct. 21 at 11:40 PM
$CVRX I’m excited to see if these new site launches get revenue per center over 2 per quarter. If they don’t, it’s all PR.
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 21 at 6:37 PM
$CVRX We're proud to support Dr. Tara Hrobowski, Dr. Christiano Caldeira and the Heart Failure and CT Surgery teams at HCA Florida Largo Hospital on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1980382997833740637
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 19 at 2:01 PM
$CVRX We were honored to partner with Drs. Sevak Darbinian, Daniel Kulick, and Jay Tiogson and the team at Providence Mission Hospital on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1979197996337123804
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 17 at 4:58 PM
$CVRX INTERESTING that with hardly any news, hardly any following, CVRX in less than 6 months has more than doubled in price. On May 12th it closed at $4.75 and most messages called for doom and gloom. Of course the share price is still only about 1/3 of what it was at its peak 2 years ago.
3 · Reply
Twister8
Twister8 Oct. 17 at 2:39 PM
$CVRX trimmed
1 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 14 at 3:18 PM
$CVRX The #ASCENDHF kickoff meeting was a success, thanks to the contributions of the Course Directors, faculty, and Fellows. The collective dedication to advancing #heartfailure care, along with their commitment to ongoing learning, collaboration, and exceptional patient care, was inspiring. We're looking forward to the fellows building on this momentum and can’t wait for our next meeting! https://x.com/CVRx_Barostim/status/1977723701870104754
1 · Reply
MedDevice
MedDevice Oct. 12 at 9:02 PM
$CVRX https://x.com/cvrx_barostim/status/1967711764360876131?s=46
1 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 11 at 9:28 PM
$CVRX Post CVRx | Barostim @CVRx_Barostim Our 2nd ASCEND Fellows Summit is officially underway in Minneapolis! It's the kickoff of a multi-course program designed for Heart Failure and General Cardiology fellows to explore treatment options for Heart Failure earlier in the care continuum. We are proud to help foster scientific collaboration with this exceptional group of fellows and faculty. https://x.com/CVRx_Barostim/status/1976774914066522505
0 · Reply
MedDevice
MedDevice Oct. 9 at 5:32 PM
$CVRX https://open.spotify.com/episode/1F14sQLvtg9igV04xpISKk?si=Anz_1_-DQS2swC7oDe1BXQ
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 8 at 6:52 PM
$CVRX Congratulations to Dr. Jeffrey Keenan, Dr. @FudimMarat , Todd McVeigh, PA, Leilani Gomez, RN, and the team at Duke University Hospital on successfully completing their 25th #Barostim implant! Thank you for providing innovative therapy options to improve the lives of patients living with #heartfailure. https://x.com/CVRx_Barostim/status/1975685801523450332
0 · Reply
billsmall
billsmall Oct. 5 at 6:27 PM
$CVRX Love the option for folks and the positive changes for them. From an investment standpoint it's challenging for sure. I'm going out on a limb here (As I'm just learning about this) and state it most likely remains a slower growth business and costs will always be a challenge for a smaller company. I have to assume someone take this out and adds this to a full line of other products they already have out there and having a BP take this with it's huge salesforce could add to profits. (Medtronic? Boston Scientific? Examples) Thoughts and any fair price projections if someone was to take them out? Thx and Good luck all.
1 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 5 at 6:01 PM
$CVRX While some on this message board in the past had objected to postings about first implants and satisfied patients, one of the few ways it can be determined how the company is doing is by knowing about those things. Lately it seems that there has been a plethora of announcements of first implants, satisfied Barostim patients and also reporting by Implant Centers of multiple implantations of 10, 35, 100 or even those having reached 200 implants. This information seems to imply that Barostim is becoming more successful and that is of utmost importance of the success of CVRX and the investments of those who have chosen to believe that the stock has good upside potential. Successful investing depends on optaining as much knowledge of the investment as is available.
2 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 5 at 5:44 PM
$CVRX David’s congestive #heartfailure left him struggling to breathe and confined to a chair. Since receiving #Barostim, he’s regained energy, rediscovered his passion for working on cars, and is enjoying life again with his wife. https://x.com/CVRx_Barostim/status/1973796810675339318
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 5 at 5:43 PM
$CVRX Kenneth N. Sable, MD, MBA, FACEP @KennethSableMD · Oct 2 @HMHNewJersey Jersey Shore UMC’s Advanced Heart Failure team provided their 35th patient with Barostim Neo™. This treatment alternative for congestive heart failure improves quality of life. https://x.com/KennethSableMD/status/1973816442614403093
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 5 at 5:41 PM
$CVRX Congratulations to Dr. Sateesh Kesari, Dr. Aaron Kulwicki, and their teams at @TriHealth Bethesda North Hospital on their 10th #Barostim implant! Thanks for your dedication to providing innovative therapy options to improve the lives of patients with #heartfailure. https://x.com/CVRx_Barostim/status/1974178262835450055
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 5:19 PM
$CVRX What is CVRX share price value?Using traditional methods for valuation, CVRX would appear to be quite undervalued at around $8. Some key factors: "The gross margin for implantable medical device companies varies, but strong, large players can achieve margins exceeding 20% or even 30%." CVRX has been producing Gross Margins of around 80%. "Average Price to Sales ratio for Medical Device companies is 4.4." With Gross Margins of more than double the average, it would not seem extreme to assign a P/S ratio for CVRX of 8. Using historical revenue figures has shown that average revenue per implant center is about $286,000. CVRX started 2025 with 233 implant centers so normal revenue total for the year would be about $67M. Using that figure a P/S ratio of 8, and outstanding shares of 26M, a fair value for CVRX shares would be $20.60. Since CVRX is still not profitable and in an unstable economy and market, taking 25% off that figure would bring it to about $15 per share.
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:37 AM
$CVRX We’ve completed our 20th Barostim placement for CHF treatment. This achievement highlights innovation, teamwork, and most importantly—hope for patients. Great job team! https://x.com/HCrespoSotoMD/status/1973205542555492722
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:36 AM
$CVRX We were proud to support Dr. Tim Fuller, Travis Polk, NP, and the team at Banner North Colorado Medical Center on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1973146795539832838
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:34 AM
$CVRX Barostim Baroreflex (Activation Therapy) is an innovative, FDA-approved implantable medical device, the world’s first neuromodulation device specifically for heart failure management, using gentle electrical pulses to activate the body’s natural baroreflex system—the mechanism that helps regulate blood pressure, heart rate, and vascular function. https://x.com/noble_road/status/1973140769155264638
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:33 AM
$CVRX Mega Doctor News @MegaDoctor · Sep 30 Earlier this month, Dr. Luis Reyes, a board-certified general, vascular and bariatric surgeon affiliated with STHS Heart, performed the first Barostim NEO® implant at the facility on a 57-year-old male patient living with congestive heart failure. https://x.com/MegaDoctor/status/1972891893181604170
0 · Reply